An official website of the United States government
Home
Name
Taurolin
Alternate Names
TAS-103
Taurolidine
Abbreviations
None
Category
Ancillary Agent
Subcategory
Anti-infective
NSC Number
None
Primary Site
Histology
None
Remarks
Phase I (breast, lung) Phase II (brain) Phase III (ovarian) Broad spectrum antibiotic apoptosis. No apparent activity against malignancy. Carter-Wallace, Bristol-Myers Squibb.
Coding
This drug should NOT be coded
